The global uveitis treatment market, valued at USD 616.7 million in 2022, is projected to grow at a steady compound annual growth rate (CAGR) of 5.9% during the forecast period from 2023 to 2030, reaching USD 975.6 million by the end of 2030.
Uveitis is a group of inflammatory diseases that affect the uvea, the middle layer of the eye. It can lead to vision loss if not treated...